Clinical trial
Anti TNF α Improves Endothelial Dysfunction in IBD Patients
NCT01881464 is registered in ClinicalTrials.gov with Carmel Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anti TNF α Improves Endothelial Dysfunction in IBD Patients
- Lead sponsor
- Carmel Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 31, 2014
- Completion date
- June 30, 2018
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
crohn's disease